Dual-targeting VEGFR1 and PD-L1 CAR-T for Pleural, Peritoneal, or Leptomeningeal Metastases

Clinical trial NCT05477927 · RECRUITING

Trial details

NCT number: NCT05477927
Sponsor: Sichuan University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Peritoneal Effusion Malignant Ascites Serous Cavity Metastatises Leptomeningeal Metastases

Start date: 2023-02-15
Primary completion: 2027-06-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.